A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status

Publisher： Bentham Science Publishers

E-ISSN： 1875-6387|2|1|59-66

ISSN： 1573-398X

Source： Current Respiratory Medicine Reviews, Vol.2, Iss.1, 2006-02, pp. : 59-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does surgery improve prognosis in patients with small-cell lung carcinoma?

By Jones Christopher D.   Cummings Ian G.   Shipolini Alex R.   McCormack David J.  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 3, 2013-03 ,pp. : 375-380

Oxford University Press

Access to resources Recommend Favorite

Taxanes in the Treatment of Non-Small Cell Lung Cancer

By Fanucchi Michael   Khuri Fadlo R.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 3, 2006-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

Response to Cisplatin-Etoposide Treatment and Survival in Patients with Small-Cell Lung Cancer in North Lebanon

By  

Medical Principles and Practice, Vol. 12, Iss. 2, 2003-03 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Diagnostic Performance of 18 F-FDG PET/CT for Lymph Node Staging in Patients with Operable Non-small-cell Lung Cancer and Inflammatory Lung Disease

By An Young-Sil  

Lung, Vol. 186, Iss. 5, 2008-10 ,pp. : 327-336

Springer Publishing Company

Access to resources Recommend Favorite

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

By Ardizzoia A.  

Lung, Vol. 182, Iss. 1, 2004-01 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite